ExploreWatchlistsPricing
  1. US-listed companies
  2. Jaguar Health, Inc.
  3. Financials
  4. Research & development

Jaguar Health, Inc. (JAGX)

Market cap
$42.83M
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 202525+50.92%
Dec 31, 202417-11.05%
Dec 31, 202319+5.38%
Dec 31, 202218+17.03%
Dec 31, 202115+135.13%
Dec 31, 20206+10.19%
Dec 31, 20196+12.90%
Dec 31, 20185+20.74%
Dec 31, 20174-40.76%
Dec 31, 20167+11.29%
Dec 31, 20156

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat